Results 121 to 130 of about 3,279 (166)

Add-on iguratimod or tacrolimus in methotrexate in patients with rheumatoid arthritis not achieving remission with methotrexate: a retrospective propensity score-matched study. [PDF]

BMC Rheumatol
Kishimoto Y, Nakazawa K, Uemura M, Kuranobu K.   +3 more
europepmc   +1 more source

The MIDAS SDAI implementation [PDF]

, 1996
Thomas D, Greenough C
core   +1 more source

Effects of Intravenous Lidocaine on Rheumatoid Arthritis in Preclinical Rat Model and Clinical Trial. [PDF]

J Pain Res
Xia M, Zhang B, Quan J, Zhang J, He C.
europepmc   +1 more source

Patient-reported outcome measures (PROMs) and clinical decision-making in inflammatory rheumatic conditions: a systematic review. [PDF]

Rheumatol Adv Pract
Grange J, Prior JA, Packham J, Somer M, Parsons H, Haywood KL.   +5 more
europepmc   +1 more source

Trajectory of lipid profiles in rheumatoid arthritis patients receiving tofacitinib: Evidence from the prospective CENTRA cohort. [PDF]

Br J Clin Pharmacol
Huang H, Geng Y, Fan Y, Zhao J, Zhang Z.
europepmc   +1 more source

Menopausal Status and Disease Outcomes in Women With Rheumatoid Arthritis Receiving Anti-tumor Necrosis Factor (TNF) and Anti-IL-6 Therapies. [PDF]

Cureus
Ghoullam G, El Binoune I, Amine B, El Moubarik I, Zemrani S, Rostom S, Bahiri R.   +6 more
europepmc   +1 more source

Dose reduction and discontinuation of non-tumor necrosis factor (TNF) biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) for people with rheumatoid arthritis in remission or low disease activity. [PDF]

Cochrane Database Syst Rev
Li YJ, Lopez-Olivo MA, Geng Y, Tayar JH, Suarez-Almazor ME.   +4 more
europepmc   +1 more source

Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study. [PDF]

Rheumatol Ther
Baldi C, Celletti E, Bugatti S, Govoni M, Cazzato M, Picchianti Diamanti A, Fornaro M, Guggino G, Navarini L, D'Agostino MA, Quartuccio L, Ciccia F, Dagna L, Stobbione P, Triggiani M, Viapiana O, Giardina A, Moroncini G, Caporali R, Bazzani C, Tirri E, Lomater C, Di Fino S, Morello F, Selmi C.   +24 more
europepmc   +1 more source

Elevated serum Slit3 independently predicts disease activity and interstitial lung disease in rheumatoid arthritis. [PDF]

Clinics (Sao Paulo)
Zhang X, Shi M, Guo D, Yu Y, Zhang H, Chen G.   +5 more
europepmc   +1 more source

Achievement and Maintenance of Disease Targets with Upadacitinib in Rheumatoid Arthritis: 2-Year Outcomes from the UPHOLD Real-World Study. [PDF]

Rheumatol Ther
Östör A, Feist E, Sidiropoulos P, Avouac J, Rebella M, Namas R, Buttgereit F, Conaghan PG, Romero AB, McDearmon-Blondell EL, Lagunes-Galindo I, Gao T, Kadakia A, Shaw T, Attar S.   +14 more
europepmc   +1 more source